SPINI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 114
EU - Europa 93
NA - Nord America 60
SA - Sud America 26
AF - Africa 7
Totale 300
Nazione #
US - Stati Uniti d'America 58
SG - Singapore 53
HK - Hong Kong 34
BR - Brasile 21
DE - Germania 21
IT - Italia 21
CN - Cina 14
FI - Finlandia 12
FR - Francia 9
RU - Federazione Russa 9
NL - Olanda 6
AT - Austria 5
AR - Argentina 3
KR - Corea 3
TG - Togo 3
VN - Vietnam 3
ES - Italia 2
GR - Grecia 2
MX - Messico 2
PL - Polonia 2
TR - Turchia 2
BD - Bangladesh 1
BH - Bahrain 1
CH - Svizzera 1
CM - Camerun 1
CO - Colombia 1
DK - Danimarca 1
IE - Irlanda 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 300
Città #
Hong Kong 34
Singapore 22
Dallas 14
Munich 13
Verona 9
Helsinki 8
Ashburn 7
Amsterdam 4
New York 4
Nuremberg 4
Turku 4
Brooklyn 3
Englewood 3
Lomé 3
The Dalles 3
Vienna 3
Athens 2
Beijing 2
Boardman 2
Catania 2
Chions 2
Falkenstein 2
Genoa 2
Ho Chi Minh City 2
Maastricht 2
Mexico City 2
Mistretta 2
Shijiazhuang 2
Alegre 1
Ankara 1
Asunción 1
Basra 1
Bom Jardim de Minas 1
Brasília 1
Bredasdorp 1
Buenos Aires 1
Campinas 1
Changsha 1
Chicago 1
Dublin 1
Escada 1
Espírito Santo do Pinhal 1
Frankfurt am Main 1
Hefei 1
Indaiatuba 1
Isa Town 1
Itajubá 1
Itaquaquecetuba 1
Kütahya 1
La Consulta 1
Lombard 1
Los Angeles 1
Madrid 1
Maranguape 1
Milan 1
Moscow 1
Nairobi 1
Nantes 1
New Haven 1
Pacatuba 1
Pedregulho 1
Pelotas 1
Porto Alegre 1
Puerto Rico 1
Quận Hai 1
Recife 1
Rio de Janeiro 1
Riyadh 1
Salt Lake City 1
Santa Clara 1
Santiago de Cali 1
Shanghai 1
St Louis 1
Stockholm 1
São Joaquim de Bicas 1
São João del Rei 1
São Paulo 1
Tokyo 1
Vargem Grande 1
Várzea Paulista 1
Warsaw 1
Wroclaw 1
Wuhan 1
Totale 217
Nome #
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network 63
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project 47
Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter] 42
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project 35
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project 34
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network 34
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance 28
Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis 23
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project 22
Totale 328
Categoria #
all - tutte 1.561
article - articoli 1.561
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202450 0 0 0 0 0 0 6 4 1 0 21 18
2024/2025179 18 2 8 10 3 15 11 8 12 43 19 30
2025/202699 44 50 5 0 0 0 0 0 0 0 0 0
Totale 328